For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.
Male gender, excessive daytime sleepiness, and presence of metabolic syndrome were among the risk factors for obstructive sleep apnea in major depression.
Depression is one of the most commonly reported complications resulting from stroke.
Patient's with depression that have Parkinson's disease have impaired white matter integrity.
Brexanolone was well tolerated among study participants.
Frequency of migraine with or without aura may be correlated with symptoms of anxiety and depression.
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
Female sex, dependency, high pain scores, and lower Mini-Mental State Examination scores were correlated with higher depression scores.
For patients with comorbid depression and TBI, NILT is effective in bringing remission.
Given the prevalence of depression in Parkinson's disease and the effectiveness of antidepressants, health care providers should promote adherence in clinical practice.
Previous research has found a higher prevalence of depression before and after an epilepsy diagnosis.
Escitalopram may be better for the treatment of depression than tDCS.
The longer women are exposed to estrogen during reproductive years, the less likely they are to be depressed.
Although there is currently no gold standard therapy for the treatment of fibromyalgia, a number of medications have shown modest efficacy in managing fibromyalgia-related pain, including pregabalin.
Overall, depression affects significantly more women than men.
Patients previously diagnosed with depression or anxiety did not have a greater risk of Alzheimer's.
Underlying pathophysiological mechanisms may connect depression and epilepsy.
A study aimed to clarify the relationship between anxiety and depression in patients with multiple sclerosis.
NMDA receptor signaling is increased in patients with depression and reduced in those with schizophrenia.
As dementia worsens, caregivers often have to report symptoms on behalf of the patient, and they tend to report more depressive symptoms than patients do.
Self-guided iCBT was more effective for depressive symptom severity and treatment response.
Among older adults with subthreshold depression, collaborative care was linked to a decrease in PHQ-9 scores.
Among ICH survivors, 63% developed both depression and dementia during a 5-year follow-up study.
Nearly half of seniors taking these drug combinations didn't have a formal diagnosis of a mental health condition, insomnia, or pain condition.
There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.
Varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Prevalence of depression or depressive symptoms was 27.2% while suicide ideation was 11.1%.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Neurology Advisor Articles
- Guidelines: AAN Recommends Exercise, Cautious Prescribing for Patients With Mild Cognitive Impairment
- Galcanezumab Significantly Reduces Migraine Headaches vs Placebo
- Noninvasive Vagus Nerve Stimulation Effective for Episodic Cluster Headaches
- Migraine Risk Significantly Reduced With Investigational Drug
- Guidelines: Opioids for the Treatment of Refractory Restless Legs Syndrome
- Treating Levetiracetam-Induced Behavioral Effects With Vitamin B6
- Apixaban Not Superior to Warfarin for Reducing Stroke Risk in Atrial Fibrillation
- Electrostimulation Plus Task Training Improves Upper Limb Function After Stroke
- Stroke Neurocognitive Outcomes Improved With Gingko Biloba Extract
- Subcortical Microinfarcts Associated With Decreased Blood Pressure in Elderly